[Clinical Study and Economic Evaluation of High-Dose Etoposide Combined with Mecapegfilgrastim for Autologous Peripheral Blood Stem Cell Mobilization in Patients with Lymphoma]
{{output}}
Objective: To investigate the efficacy, safety and cost-effectiveness of single high-dose etoposide (VP-16) combined with mecapegfilgrastim for mobilizing autologous peripheral blood stem cells (APBSC) in patients with lymphoma. ... ...
